SMC Spain

SMC Spain

SMC Spain
Position
Topics

The use, toxicity and ecological harm of pesticides are increasing at the global scale

A study published in Science shows a global increase in the toxicity and ecological harm caused by pesticides, contrary to the United Nations’ goal of halving pesticide-related risks by 2030. The authors analysed Total Applied Toxicity (TAT), which accounts for both pesticide use and toxicity, at a global scale between 2013 and 2019. The data covered the risks of 625 pesticides across eight species groups and 65 countries, representing 79.4% of global cropland. TAT increased in six of the eight species groups, including all invertebrate groups and terrestrial plants, and only Chile would meet the target of reducing pesticide risk by 50% by 2030.

0

Device-independent quantum key distribution at 100 kilometers achieved for the first time

Device-independent quantum key distribution (DI-QKD) is a key step toward the quantum internet, as it provides the highest level of cryptographic security allowed by quantum mechanics. For it to have practical applications in a communication network, it must be achieved between nodes that are sufficiently far apart. An article published in Science demonstrates DI-QKD for the first time between two single-atom nodes connected by 100-kilometer-long fibers. This distance would be sufficient to achieve cryptographic security at a metropolitan scale.

0

The incidence of autism is similar in boys and girls, although boys are diagnosed earlier

A study published in The BMJ suggests that the incidence of autism spectrum disorder (ASD) is comparable between boys and girls. The study included a sample of more than 2.7 million people born in Sweden between 1985 and 2020 who were followed from birth to a maximum age of 37. More than 78,000 were diagnosed with ASD. It was observed that boys are usually diagnosed between the ages of 10 and 14, five years earlier than girls. By the age of 20, the proportion of diagnoses is almost equal between the sexes. Before the age of 10, the ratio is 3:1 in favour of boys.

0

A menstrual blood test detects the human papillomavirus (HPV) and could serve as an alternative in cervical cancer screening

A team in China has studied the ability of a test to detect the human papillomavirus (HPV)—responsible for the vast majority of cervical cancers—in menstrual blood from more than 3,000 women. The results indicate that the test is comparable to current screening performed in medical offices. According to the researchers, “Using menstrual blood for HPV testing is practical and non-invasive, allowing women to collect samples at home and thus potentially offering a practical way to expand access to screening.” The study is published in The BMJ. 

0

Researchers study the role of a new brain network in Parkinson's disease

A study published in Nature suggests that a brain network that controls the execution of actions (SCAN), which was described in 2023, plays an important role in Parkinson's disease. Focusing treatments—such as transcranial stimulation—on the SCAN rather than other brain regions associated with movement could improve their effectiveness, according to the research.

0

A review finds no differences in physical performance between trans women and cis women, even though they have more muscle mass

The inclusion of transgender women in women's sports categories is a controversial decision. To compare body composition and physical fitness between transgender and cisgender women, a team from Brazil has conducted a meta-analysis encompassing 52 studies and 6,485 individuals, analysing these values before and after gender-affirming hormone therapy. Although trans women showed greater lean mass—an indicator of muscle mass—there were no significant differences in upper or lower body strength, nor in maximum oxygen consumption, compared to cis women one to three years after hormone therapy. ‘The current evidence is, for the most part, of low certainty and heterogeneous quality, but it does not support theories about the inherent athletic advantages of trans women over cis women,’ say the authors of the study, published in the British Journal of Sports Medicine.

0

Four out of ten cancer cases due to modifiable factors such as tobacco, according to WHO analysis

In 2022, approximately four out of every 10 new cancer cases worldwide were due to modifiable risk factors, primarily tobacco or alcohol consumption and infections, including those caused by the human papillomavirus or H. pylori bacteria. These are some of the conclusions of a global study led by the World Health Organisation (WHO) and its International Agency for Research on Cancer (IARC), published in Nature Medicine. In Spain, 41.8% of cancer cases in men are attributed to modifiable external factors, compared to 26.1% in women, with smoking remaining the main factor (28.5% and 9.9%, respectively). The analysis is based on data from 185 countries.

0

Pedro Sánchez announces that Spain will ban children under 16 from accessing social media

The Prime Minister, Pedro Sánchez, announced on Tuesday from Dubai that Spain will ban children under the age of 16 from accessing social media and will adopt other measures to increase control over digital platforms and ensure that their executives are held accountable for violations. Sánchez made this announcement in his speech to the plenary session of the World Government Summit and announced that next week the government will approve a series of measures, including this ban.

 

0

Administering immunotherapy and chemotherapy in the morning could improve their effectiveness against lung cancer

A phase 3 clinical trial conducted in China tested 210 patients with advanced non-small cell lung cancer—the most common type—to see whether the time of day when immunotherapy and chemotherapy were administered influenced their effectiveness. The data indicate that, on average, those who received therapy after 3 p.m. did not see their cancer worsen for 5.4 months. In contrast, those who received it before that time did not see their cancer worsen for an average of 11.7 months, almost twice as long. Overall, response rates were 56.2% and 69.5%, respectively. The results, published in Nature Medicine, suggest that scheduling therapy early in the day may offer a simple and cost-free way to improve treatment efficacy.

 

0

A clinical trial involving more than 100,000 women shows that AI improves breast cancer screening

Between April 2021 and December 2022, more than 100,000 women in Sweden were randomly assigned to either AI-assisted mammography screening or double reading, where two radiologists review each mammogram without the aid of AI. AI-assisted screening identified more women with significant cancers without a higher rate of false positives and also achieved a 12% reduction in the rate of interval cancers—those that appear between mammograms because they went unnoticed or are newly developed and more aggressive—compared to the double reading procedure. This is the first clinical trial of its kind, and its results are published in The Lancet.

0